Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2013
12/04/2013CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels
12/03/2013US8598346 Synthesis of cyclic amidines
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2530302C Novel aminobenzophenone compounds
11/2013
11/28/2013WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS
11/28/2013WO2013173905A1 Biocidal compounds and methods for using same
11/28/2013US20130317001 N-substituted benzamides and methods of use thereof
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/28/2013US20130316248 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
11/27/2013EP2666769A1 Substituted B-amino acid derivatives as CXCR3 receptor antagonist
11/27/2013CN103415509A Ester compound and use thereof
11/27/2013CN103409134A Bifluorescence-emission organic light-emitting material and preparation method thereof
11/27/2013CN103408499A Organic non-linear optical material containing nitro-substituted imidazolyl, and preparation method and application of organic non-linear optical material
11/27/2013CN103408498A Method for preparing 5-(2-methylmercapto-ethyl)-hydantoin by utilizing crude hydrocyanic acid gas
11/27/2013CN103408497A L-carnosine preparation method
11/27/2013CN103408496A Bis-imidazole ionic crystal and preparation method thereof
11/27/2013CN103408495A Synthesis process of phentolamine mesilate
11/27/2013CN103406065A Novel amido-linkage imidazolium salt gemini surfactant and preparation method thereof
11/26/2013US8592419 Ceramides and apoptosis-signaling ligand
11/26/2013CA2585615C Dicarboxamide derivatives and their use as factor xa inhibitors
11/26/2013CA2562131C Process for producing n,n'-carbonyldiimidazole
11/21/2013WO2013173218A1 1,3-diaryl-substituted heterocyclic pesticides
11/21/2013WO2013172350A1 Novel graphene nanodispersion and method for preparing same
11/21/2013WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2663315A1 Novel n-halamine acrylamide monomers and copolymers thereof for biocidal coatings
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP2202227B1 Novel histidine derivative
11/20/2013EP1697330B1 Method for the production of n,n -carbonyldiazoles
11/20/2013CN103402986A Modulators of S1P receptors
11/20/2013CN103402516A Compounds useful as antiviral agents, compositions, and methods of use
11/20/2013CN103396550A Preparation method of imidazole functionalized amphiphilic periodic mesoporous organic silicon material
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396369A Method for preparing 2-chloro-4-nitroimidazole
11/20/2013CN103396368A Application of free radical of nitroxide to treatment of ischemia reperfusion injury
11/20/2013CN103394329A Carboxyl functionalized ionic liquid/hydrotalcite-like compound composite material, and preparation method and application thereof
11/19/2013US8586763 Process for producing N-halogenated hydantoins
11/19/2013US8586762 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
11/19/2013US8586617 Aminomethyl-4-imidazoles
11/19/2013US8586536 Neprilysin inhibitors
11/14/2013WO2013170030A1 Antibacterial agents
11/14/2013US20130303784 Method for preparing aminoethyl imidazolidinone and the thiocarbonyl thereof
11/14/2013US20130303783 Device and process for continuous phosgenation
11/14/2013US20130303572 Novel inhibitors of matrix metalloproteinases
11/14/2013US20130303505 Tgr5 agonists
11/13/2013EP2662365A1 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
11/13/2013EP2662353A2 Antibacterial agents
11/13/2013CN103387544A Preparation method of imidazole ionic liquid
11/13/2013CN101671336B Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580833 Substituted imidazole derivatives and methods of use thereof
11/12/2013US8580297 Components for producing amphoteric liposomes
11/12/2013CA2601481C Process for the preparation of opioid modulators
11/07/2013WO2013164845A1 A solvent system for dissolution of pulp and polymer
11/07/2013WO2013030068A3 Method for producing a methionine salt
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296346 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
11/07/2013US20130295040 Polymer
11/07/2013DE112007003375B4 Imidazolderivate, die Apoptose induzieren, und deren therapeutische Anwendung Imidazole derivatives induce apoptosis, and their therapeutic use
11/06/2013CN103382179A Ingavirin polymorph and its preparation method
11/06/2013CN102365266B Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
11/06/2013CN102167683B Bivalent cation magnetic ionic liquids and preparation method thereof
11/06/2013CN102050747B Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis
11/06/2013CN101935285B Hexafluoroaluminate of organic onium, and preparation method and application thereof
11/06/2013CN101899006B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
11/05/2013US8575359 Acid-sensitive linkers for drug delivery
11/05/2013CA2481202C Functionalized ionic liquids, and methods of use thereof
10/2013
10/31/2013WO2013161739A1 Organic electroluminescence element, illumination device and display device
10/31/2013WO2013159741A1 Device and method for preparing hydantoin
10/31/2013US20130289088 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
10/31/2013US20130289047 Heteroarylthio derivatives and analogues
10/30/2013EP2656842A2 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
10/30/2013EP2656841A1 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655336A1 Cancer targeting using carbonic anhydrase isoform ix inhibitors
10/30/2013EP2655335A1 Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
10/30/2013EP2655334A1 Compositions and methods useful for treating diseases
10/30/2013CN103380115A Sulfur derivatives as chemokine receptor modulators
10/30/2013CN102177125B Process for producing alpha-hydroxyketone compound
10/30/2013CN102099344B Imidazole carboxamides
10/30/2013CN101061099B High stability diionic liquid salts
10/29/2013US8569510 White-emitting compounds using excited-state intramolecular proton transfer, organic electroluminescent element and laser material using the same
10/29/2013US8569352 Imidazole based LXR modulators
10/29/2013US8569336 Compounds for the treatment of inflammatory disorders
10/24/2013WO2002094883A3 One-step process for the preparation of halide-free hydrophobic salts
10/24/2013US20130281709 Process for producing alpha-hydroxyketone compound
10/24/2013US20130281389 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
10/23/2013EP2653465A1 Opioid receptor modulators
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/23/2013CN103370306A Glucagon receptor modulator
10/23/2013CN103364553A Enzyme linked immunosorbent assay kit for detecting nitroimidazole drugs and application thereof
10/23/2013CN103360321A Nitrofurantoin metabolite hapten as well as preparation method and application thereof
10/23/2013CN103360320A Preparation method for 1-methylhydantoin
10/23/2013CN103360319A Method for producing histidine by taking amino acid I mother solution as raw material
10/23/2013CN103360318A Preparation method of sulfonyl azide compounds
10/23/2013CN103360270A Serine derived chiral amine compound as well as preparation method and application thereof
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 345